Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market

ABBOTT INDIA LTD.

  • NSE CodeABBOTINDIAEQ
  • BSE Code500488
  • ISININE358A01014
  • IndustryPharmaceuticals


Company Information

Management

Ms. Sangeeta Shetty

Co. Secretary & Compl. Officer

Ms. Maithilee Mistry

Chief Financial Officer

Mr. Prithwish Banerji

Commercial Director

Mr. Harshraj Madan

Commercial Director

Incorporation Year

22/08/1944

Registered Address

Registered Office : 3, Corporate Park, Sion-Trombay Road,
Mumbai, Maharashtra - 400071
Tel: 022-67978888
Fax: 022-67978727

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

investorrelations.india@abbott.com

Website

http://www.abbott.co.in

Listing

BSE, MCXSX, NSE

Corporate News

Abbott India - Unaudited Financial Results Of The Com...

05-Nov-2026|6:55PM

Unaudited Financial Results of the Company for the quarter and half year en

Abbott India Q2 net profit up 9.19% at Rs 453.45 cr

05-Nov-2026|6:50PM

The company reported standalone net profit of Rs 453.45 crore for the quart

Abbott India - Board Meeting Outcome for Outcome Of B...

05-Nov-2026|6:45PM

Unaudited Financial Results of the Company for the quarter and half year en

Abbott India - Board Meeting Intimation for Consideri...

26-Oct-2026|3:53PM

Abbott India Ltdhas informed BSE that the meeting of the Board of Directors

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug114.11323.55
Aarti Drug508.754,643.36
Aarti Pharma1,010.509,163.20
Abbott India26,600.0056,523.14
Accent Micro609.351,461.77

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
SBI Large &am..835.452.06
Nippon India ..400.400.74
Axis Midcap F..370.431.10
Canara Robeco..359.071.46
Nippon India ..213.062.32

Board Meetings

DatePurpose
05/11/2026Quarterly Results
12/08/2026Quarterly Results
11/05/2026Audited Results & F..
12/02/2026Quarterly Results
06/11/2025Quarterly Results